-+ 0.00%
-+ 0.00%
-+ 0.00%

Grace Therapeutics CEO Prashant Kohli acquires 100,000 common shares for $214,000

PUBT·09/10/2026 11:54:50
Listen to the news
Grace Therapeutics CEO Prashant Kohli acquires 100,000 common shares for $214,000
  • Grace Therapeutics CEO Prashant Kohli bought 100,000 common shares at USD 2.14 each.
  • Directly held stake rose to 121,357 shares following the purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-036125), on September 10, 2026, and is solely responsible for the information contained therein.